Back to REGN overview

REGN Regeneron Pharmaceuticals PE ratio, current and historical analysis

As of Jun 14, 2024, the Regeneron Pharmaceuticals stock's PE ratio is 28.7. This takes into account the latest EPS of $36.12 and stock price of $1,036.52. The PE ratio marks an increase of 27% from its last 4 quarters average of 22.6.

REGN PE ratio history

How has REGN's PE ratio performed in the past

The PE ratio of Regeneron Pharmaceuticals has averaged 37.88 over the last ten years. The current P/E ratio of 28.7 is 24% lower than the historical average. Looking back at the last ten years, REGN's PE ratio peaked in the Mar 2015 quarter at 132.01, when the price was $451.48 and the EPS was $3.42. The lowest point was in the Dec 2021 quarter, when it reached 8.27 with a price of $631.52 and an EPS of $76.4.

Average
37.88
Median
23.36
Minimum
8.27
Maximum
132.01

Regeneron Pharmaceuticals PE ratio by year

Maximum annual increase: 115.36% in 2022

Maximum annual decrease: -51.21% in 2016

Year PE ratio Change
2023 23.71 33.13%
2022 17.81 115.36%
2021 8.27 -44.12%
2020 14.8 -23.59%
2019 19.37 17.47%
2018 16.49 -50.57%
2017 33.36 -22.29%
2016 42.93 -51.21%
2015 87.99 -27.94%
2014 122.1 87.64%

REGN average PE ratio chart

What is the average PE ratio of REGN for the past years

REGN's current PE ratio is higher than the 3 and 5-year averages, but it is lower than its 10-year average.

3-year avg
15.84
5-year avg
16.64
10-year avg
37.88
15-year avg
38.86

REGN PE vs peers

What is REGN's PE ratio compared to its peers

REGN's PE ratio stands lower than its peer stocks AMGN and BIIB, but it is higher than JNJ's and NVS's. Regeneron Pharmaceuticals is currently trading at a higher PE ratio (28.7) than its peers average of 23.75.

Stock name PE ratio Market cap
JNJ Johnson & Johnson 9.54 $350.27B
NVS Novartis AG 14.27 $215.71B
REGN Regeneron Pharmaceuticals Inc 28.7 $114.21B
BIIB Biogen Inc 28.78 $33.73B
AMGN Amgen Inc 42.42 $160.19B
ALNY Alnylam Pharmaceuticals Inc N/A $20.29B

Frequently asked questions

What is Regeneron Pharmaceuticals's PE ratio?

REGN stock has a price to earnings ratio of 28.7 as of Jun 14, 2024.

What is the 3-year average PE ratio for Regeneron Pharmaceuticals (REGN)?

The 3-year average price to earnings ratio for REGN stock is 15.84.

What is the 5-year average PE ratio for Regeneron Pharmaceuticals (REGN)?

The 5-year average price to earnings ratio for REGN stock is 16.64.

What is the highest PE ratio for REGN?

Over the last ten years, the quarterly PE ratio reached its highest level at 132.01 in the Mar 2015 quarter.

How does the current PE ratio for REGN compare to its historical average?

REGN's price to earnings ratio is currently 24% below its 10-year historical average.

How is REGN's PE ratio calculated (Regeneron Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 14, 2024), Regeneron Pharmaceuticals's share price is $1,036.52. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $36.12. Therefore, Regeneron Pharmaceuticals's PE ratio for today is 28.7. PE RATIO(28.7) = STOCK PRICE($1,036.52) / TTM EPS($36.12)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.